AGNARGENICA THERAPEUTICS LIMITEDMarket sensitive

Phase 2 Trial Promising Improvements in Functional Outcomes

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFAGN announcement history

Recent AGN announcements